Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

Merck KGaA

DEEUR
← Allo screener

Merck KGaA (US:MKGAF) — Drug Manufacturers - Specialty & Generic. Numero di borse in cui sono quotate le azioni della società: 3. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

⚠ Non confonderli: c'è un'altra azienda con lo stesso nome o uno molto simile. È un registro separato — controlla il ticker, il numero di borsa e di registrazione.
  • Merck KGaA ADR — 1MRKX · MI US CIK 310158 · LEI 4YV9Y5M8S0BRK1RP0397 · ISIN US58933Y1055

Informazioni sull'azienda

Sito web
merckgroup.com
Settore
Healthcare · Drug Manufacturers - Specialty & Generic
Sede centrale
Darmstadt, Germany
Amministratore delegato
Belén Garijo
Dipendenti
60 348
Fondata
1668
Azioni in circolazione
129.24 Mln
Flottante
128.87 Mln
Capitalizzazione di mercato
59.93 Mld EUR
Insider
0%
Investitori istituzionali
57.83%
Descrizione

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Borse e ticker

BorsaTickerValutaPrezzoTipo
XETRA XetraMRK principaleEUR138.1 +0.51%azioni ordinarie
LSE London Stock Exchange0O14 IOBEUR137.725 +1.64%azioni ordinarie
US USA StocksMKGAF OTCUSD160.752 +4.22%azioni ordinarie

Prezzo su 3 mesi

giorno di rialzo giorno di ribasso data di stacco del dividendo data di pagamentoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Dividendi

Ultimi 12 mesi, XETRA:MRK: 2.2 EUR (1 pag.)

Merck KGaA (MRK) paga dividendi una volta all'anno. Negli ultimi 12 mesi, sono stati pagati 2.2 EUR per azione (pagamenti: 1). Questo rappresenta circa il 1.59% del prezzo attuale delle azioni. In base alla storia dei pagamenti, la prossima data ex-dividendo è prevista intorno al 26.04.2027.

Data exPagamentoImporto%TipoTicker
2026-04-272026-04-292.2000 EUR1.6/1.6 %annualeXETRA:MRK
2025-04-282025-04-302.2000 EUR1.6/1.6 %annualeXETRA:MRK
2024-04-29—2.2000 EUR1.6/1.6 %annualeXETRA:MRK
2023-05-02—2.2000 EUR1.6/1.6 %annualeXETRA:MRK
2022-04-25—1.8500 EUR1.3/1.3 %annualeXETRA:MRK

Notizie di questa settimana

Ancora nessuna notizia dal sito della società.

pubblicità

Principali azionisti

DetentoreQuotaAzioniData del rapporto
First Eagle Funds-First…4.7%6.07 Mln2026-07-31
MFS Series Trust XVII-MF…1.78%2.3 Mln2026-06-30
First Eagle Funds-First…1.59%2.06 Mln2026-07-31
VANGUARD STAR FUNDS-Vang…1.48%1.91 Mln2026-07-31
Bridge Builder Trust-Bri…1.36%1.76 Mln2026-06-30
VANGUARD TAX-MANAGED FUN…0.98%1.27 Mln2026-06-30
MFS SERIES TRUST I-MFS R…0.76%988 0282026-05-31
iShares Trust-iShares Co…0.75%964 9962026-08-31
MFS SERIES TRUST X-MFS I…0.73%947 8552026-05-31
BNY Mellon Strategic Fun…0.41%532 2002026-05-31
Generali Investments Cee…0%6 2362026-06-30
Pacer Advisors, Inc.0%4 9262026-06-30
Reik & Co., Llc0%4 0002026-06-30
Gamma Investing LLC0%342026-09-30